β-Adrenergic receptors activate exchange protein directly activated by cAMP (Epac), translocate Munc13-1, and enhance the Rab3A-RIM1α interaction to potentiate glutamate release at cerebrocortical nerve terminals

J Biol Chem. 2013 Oct 25;288(43):31370-85. doi: 10.1074/jbc.M113.463877. Epub 2013 Sep 13.

Abstract

The adenylyl cyclase activator forskolin facilitates synaptic transmission presynaptically via cAMP-dependent protein kinase (PKA). In addition, cAMP also increases glutamate release via PKA-independent mechanisms, although the downstream presynaptic targets remain largely unknown. Here, we describe the isolation of a PKA-independent component of glutamate release in cerebrocortical nerve terminals after blocking Na(+) channels with tetrodotoxin. We found that 8-pCPT-2'-O-Me-cAMP, a specific activator of the exchange protein directly activated by cAMP (Epac), mimicked and occluded forskolin-induced potentiation of glutamate release. This Epac-mediated increase in glutamate release was dependent on phospholipase C, and it increased the hydrolysis of phosphatidylinositol 4,5-bisphosphate. Moreover, the potentiation of glutamate release by Epac was independent of protein kinase C, although it was attenuated by the diacylglycerol-binding site antagonist calphostin C. Epac activation translocated the active zone protein Munc13-1 from soluble to particulate fractions; it increased the association between Rab3A and RIM1α and redistributed synaptic vesicles closer to the presynaptic membrane. Furthermore, these responses were mimicked by the β-adrenergic receptor (βAR) agonist isoproterenol, consistent with the immunoelectron microscopy and immunocytochemical data demonstrating presynaptic expression of βARs in a subset of glutamatergic synapses in the cerebral cortex. Based on these findings, we conclude that βARs couple to a cAMP/Epac/PLC/Munc13/Rab3/RIM-dependent pathway to enhance glutamate release at cerebrocortical nerve terminals.

Keywords: Cyclic AMP (cAMP); Epac Proteins; G Protein-coupled Receptors (GPCR); Munc13–1; Neurotransmitter Release; Phospholipase C; RIM1α; Rab3A; Synaptosomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Cerebral Cortex / cytology
  • Cerebral Cortex / metabolism*
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism*
  • Enzyme Inhibitors / pharmacology
  • GTP-Binding Proteins / metabolism*
  • Glutamic Acid / metabolism*
  • Guanine Nucleotide Exchange Factors / metabolism*
  • Isoproterenol / pharmacology
  • Mice
  • Naphthalenes / pharmacology
  • Nerve Tissue Proteins / metabolism*
  • Presynaptic Terminals / metabolism
  • Protein Transport / drug effects
  • Protein Transport / physiology
  • Receptors, Adrenergic, beta / metabolism*
  • Synaptic Membranes / metabolism
  • Synaptic Transmission / physiology
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism
  • rab3A GTP-Binding Protein / metabolism*

Substances

  • Adjuvants, Immunologic
  • Adrenergic beta-Agonists
  • Enzyme Inhibitors
  • Epac protein, mouse
  • Guanine Nucleotide Exchange Factors
  • Naphthalenes
  • Nerve Tissue Proteins
  • Receptors, Adrenergic, beta
  • Rims1 protein, mouse
  • Unc13a protein, mouse
  • Colforsin
  • Glutamic Acid
  • Cyclic AMP
  • Type C Phospholipases
  • GTP-Binding Proteins
  • rab3A GTP-Binding Protein
  • calphostin C
  • Isoproterenol